1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
Bååth, Maria LU ; Jönsson, Jenny-Maria LU ; Westbom Fremer, Sofia LU
; Martin de la Fuente, Laura
LU
; Tran, Lena
LU
; Malander, Susanne
LU
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
; Honeth, Gabriella
LU
and Hedenfalk, Ingrid
LU
(2021)
In Genes
12(5).
Mark
-
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014 : A population-based cohort study
Leandersson, Pia LU
; Hogberg, Thomas
LU
; Dickman, Paul W.
; Malander, Susanne
LU
and Borgfeldt, Christer
LU
(2021)
In BMC Cancer
21(1).
Mark
- 2020
-
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Westbom-Fremer, Sofia LU
; Arildsen, Nicolai Skovbjerg
LU
; Hartman, Linda
LU
; Malander, Susanne
LU
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
and Hedenfalk, Ingrid
LU
(2020)
In Virchows Archiv : an international journal of pathology
477(1).
p.83-91
Mark
-
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
Bååth, Maria LU ; Westbom-Fremer, Sofia LU
; Martin de la Fuente, Laura
LU
; Ebbesson, Anna
LU
; Davis, Juliette
; Malander, Susanne
LU
; Måsbäck, Anna
LU
; Kannisto, Päivi
LU
and Hedenfalk, Ingrid
LU
(2020)
In Molecular and Cellular Oncology
7(6).
Mark
-
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
Corvigno, Sara ; Mezheyeuski, Artur ; De La Fuente, Laura Martin LU ; Westbom-Fremer, Sofia LU
; Carlson, Joseph W.
; Fernebro, Josefin
LU
; Åvall-Lundqvist, Elisabeth
; Kannisto, Paivi
LU
; Hedenfalk, Ingrid
LU
and Malander, Susanne
LU
, et al.
(2020)
In Gynecologic Oncology
159(3).
p.860-868
Mark
-
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
Leandersson, Pia LU
; Åkesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Malander, Susanne
LU
and Borgfeldt, Christer
LU
(2020)
In PLoS ONE
15(10 October).
Mark
- 2019
- Pattern of endocrine treatment for epithelial ovarian cancer in the Southeast medical region of Sweden : a population-based study
-
A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
Huttenhain, Ruth ; Choi, Meena ; Martin de la Fuente, Laura LU ; Oehl, Kathrin ; Chang, Ching-Yun ; Zimmermann, Anne-Kathrin ; Malander, Susanne LU ; Olsson, Hakan LU
; Surinova, Silvia
and Clough, Timothy
, et al.
(2019)
In Molecular and Cellular Proteomics
18(9).
p.1836-1850
Mark
- Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
-
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
Arildsen, Nicolai Skovbjerg LU ; Martin de la Fuente, Laura LU ; Måsbäck, Anna LU ; Malander, Susanne LU ; Forslund, Ola LU ; Kannisto, Päivi LU and Hedenfalk, Ingrid LU
(2019)
In Scientific Reports
9(1).
p.1-8
Mark